Duract (bromfenac) was on the U.S. market less than a year
August 1998
Duract (bromfenac) was on the U.S. market less than a year.It was never approved by HPB...but many Canadians crossed the borderto get this effective NSAID.
When the FDA pulled it, the HPB also issued a warning.
This NSAID worked well for acute pain, but got pulled becauseof reports of severe hepatic failure in patients who used Duract formore than 10 days or had pre-existing hepatic disease.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive